However, some individuals with type 1 diabetes may develop insulin resistance due to obesity or long-term insulin therapy, a condition sometimes referred to as “double diabetes,” which may increase the risk of developing NAFLD (Memaj and Jornayvaz, 2022). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.